The 2026 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer (IASLC), is being held in Seoul, Republic of Korea, from September 12 to 15, 2026. The opening ceremony and IASLC Distinguished Service Awards presentation took place in the Plenary Hall on September 12.
Four leaders in lung cancer research and care were recognized at the ceremony: Luis M. Montuenga, Martin Carl Tammemägi, Wendy Cooper, and D. Ross Camidge. The awards honor sustained contributions across molecular pathology, thoracic oncology science, pathology and translational research, and cancer prevention and early detection.
Adi F. Gazdar IASLC Merit Award: Luis M. Montuenga
In 2019, the IASLC Board of Directors renamed the IASLC Merit Award in honor of Adi F. Gazdar, recognizing his pioneering work in molecular pathology and his lifelong commitment to lung cancer research. The award is selected annually by the IASLC Executive Committee and presented during WCLC.
The 2026 award was presented to Luis M. Montuenga of the Center for Applied Medical Research at the University of Navarra.

Fig. 1. Luis M. Montuenga receives the Adi F. Gazdar IASLC Merit Award.
Paul A. Bunn, Jr. Scientific Award: D. Ross Camidge
The Paul A. Bunn, Jr. Scientific Award recognizes lifetime scientific contributions to thoracic oncology. Paul A. Bunn, Jr. helped establish standards in the field and advanced understanding of the natural history of lung cancer, prognostic biomarkers, and treatment selection.
The award dates to 1994, when Robert Ginsberg, a thoracic surgeon in Toronto whose work advanced surgery for early-stage lung cancer, became its first recipient. It was later renamed for Bunn in recognition of his decade of service as IASLC executive director and chief executive officer.
The 2026 recipient was D. Ross Camidge of the University of Colorado Cancer Center.

Fig. 2. D. Ross Camidge, recipient of the 2026 Paul A. Bunn, Jr. Scientific Award.
Mary J. Matthews Pathology/Translational Research Award: Wendy Cooper
The Mary J. Matthews Pathology/Translational Research Award recognizes lifetime achievement in the pathology and translational research of thoracic malignancies. The award is named for Mary J. Matthews, a former senior investigator and pathologist in the Medical Oncology Branch of the US National Cancer Institute. Her work helped establish the histologic classification of lung cancer subtypes and link those subtypes with clinical course.
The 2026 award was presented to Wendy Cooper of Royal Prince Alfred Hospital.

Fig. 3. Presentation of the Mary J. Matthews Pathology/Translational Research Award.

Fig. 4. Wendy Cooper delivers her acceptance remarks.
Joseph W. Cullen Prevention/Early Detection Award: Martin Carl Tammemägi
The Joseph W. Cullen Prevention/Early Detection Award recognizes lifetime achievement in the prevention of thoracic malignancies. Cullen served as deputy director of the US National Cancer Institute’s Division of Cancer Prevention and Control and established the Smoking, Tobacco, and Cancer Program in 1982.
The award was first presented in 1994 to Jesse Steinfeld, who served as US surgeon general when the National Cancer Act of 1971 was enacted. The 2026 recipient was Martin Carl Tammemägi of Brock University.

Fig. 5. The Joseph W. Cullen Prevention/Early Detection Award presentation. Martin Carl Tammemägi was unable to attend for personal reasons.